We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

FAAH

FAAH inhibitors act on fatty acid amide hydrolase (FAAH), a serine hydrolase that ends anandamide signaling. The enzyme was cloned in 1996 as a membrane protein that hydrolyzes oleamide, anandamide and related fatty acid amides. Inhibiting FAAH raises endogenous anandamide levels without directly binding cannabinoid receptors. In 2003, URB597 increased brain anandamide and produced anxiolytic-like effects in rats. PF-3845 and PF-04457845 are covalent FAAH inhibitors, and JNJ-42165279 and BIA 10-2474 extend the set. JZL195 inhibits both FAAH and monoacylglycerol lipase (MAGL) and also appears under Lipase. FP-Biotin is a biotinylated fluorophosphonate probe for activity-based profiling of serine hydrolases.

1 Item

  • MDPD
    Cat. No.
    A74658
    CAS No.
    693265-89-3

    MDPD

    MDPD is an activator of Arabidopsis fatty acid amide hydrolase (AtFAAH), promoting increased enzymatic activity of this important regulatory enzyme. This compound is utilized in research applications focused on lipid metabolism and amide hydrolysis pathways, contributing to the understanding of fatty acid signaling processes in plant biology. MDPD's ability to enhance AtFAAH activity makes it a valuable tool for studies investigating the physiological roles of fatty acid amides in Arabidopsis.

    In stock View Details
    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...